Werba J P, Safa O, Gianfranceschi G, Michelagnoli S, Sirtori C R, Franceschini G
Center E. Grossi Paoletti, University of Milan, Italy.
Atherosclerosis. 1993 Jul;101(2):203-11. doi: 10.1016/0021-9150(93)90117-d.
The relationship between plasma lipoprotein(a) (Lp(a)) levels and other clinical/biochemical variables was investigated in 1200 consecutive hyperlipidemic patients. Plasma Lp(a) concentrations were measured by a sandwich-ELISA method, while the patients were either on diet or diet plus lipid-lowering drugs; 38% of them had a plasma Lp(a) level > 30 mg/dl. The median plasma Lp(a) concentration and the frequency of Lp(a) > 30 mg/dl were significantly lower in individuals with severe hypertriglyceridemia vs. hypercholesterolemics (HC) or mixed hyperlipidemics (M-HLP), but similar to normolipidemic healthy controls. Patients with isolated moderate hypertriglyceridemia had Lp(a) levels intermediate between HC and M-HLP subjects. The in vitro addition of triglyceride-rich lipoproteins to normotriglyceridemic plasma did not affect the Lp(a) measurement. Plasma Lp(a) concentrations in the whole hyperlipidemic population correlated negatively with triglycerides and positively with total cholesterol, HDL-cholesterol and age, being unrelated to either body mass index or lipid-lowering treatment. In HC patients, the presence of tendon xanthomas was associated with twofold higher Lp(a) levels. These findings argue for a regulatory role of triglycerides on plasma Lp(a) levels in hyperlipidemic patients.
在1200例连续的高脂血症患者中研究了血浆脂蛋白(a) [Lp(a)]水平与其他临床/生化变量之间的关系。采用夹心酶联免疫吸附测定法测量血浆Lp(a)浓度,这些患者要么接受饮食治疗,要么接受饮食加降脂药物治疗;其中38%的患者血浆Lp(a)水平>30mg/dl。与高胆固醇血症患者(HC)或混合型高脂血症患者(M-HLP)相比,重度高甘油三酯血症患者的血浆Lp(a)浓度中位数和Lp(a)>30mg/dl的频率显著更低,但与血脂正常的健康对照相似。单纯中度高甘油三酯血症患者的Lp(a)水平介于HC和M-HLP受试者之间。向正常甘油三酯血症血浆中体外添加富含甘油三酯的脂蛋白不会影响Lp(a)的测量。整个高脂血症人群的血浆Lp(a)浓度与甘油三酯呈负相关,与总胆固醇、高密度脂蛋白胆固醇和年龄呈正相关,与体重指数或降脂治疗均无关。在HC患者中,肌腱黄色瘤的存在与Lp(a)水平高出两倍有关。这些发现支持甘油三酯在高脂血症患者血浆Lp(a)水平上起调节作用。